UBE2V1 anticorps (AA 2-147)
-
- Antigène Voir toutes UBE2V1 Anticorps
- UBE2V1 (Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1))
-
Épitope
- AA 2-147
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp UBE2V1 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Ubiquitin-conjugating enzyme E2 variant 1 protein (2-147AA)
- Isotype
- IgG
- Top Product
- Discover our top product UBE2V1 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- UBE2V1 (Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1))
- Autre désignation
- UBE2V1 (UBE2V1 Produits)
- Synonymes
- anticorps CIR1, anticorps CROC-1, anticorps CROC1, anticorps UBE2V, anticorps UEV-1, anticorps UEV1, anticorps UEV1A, anticorps 0610011J09Rik, anticorps AI256840, anticorps D7Bwg1382e, anticorps CROC-1B, anticorps ubiquitin conjugating enzyme E2 V1, anticorps ubiquitin-conjugating enzyme E2 variant 1, anticorps UBE2V1, anticorps ube2v1, anticorps Ube2v1
- Sujet
-
Background: Has no ubiquitin ligase activity on its own. The UBE2V1-UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through Lys-63. This type of poly-ubiquitination activates IKK and does not seem to involve protein degradation by the proteasome. Plays a role in the activation of NF-kappa-B mediated by IL1B, TNF, TRAF6 and TRAF2. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. Promotes TRIM5 capsid-specific restriction activity and the UBE2V1-UBE2N heterodimer acts in concert with TRIM5 to generate \'Lys-63\'-linked polyubiquitin chains which activate the MAP3K7/TAK1 complex which in turn results in the induction and expression of NF-kappa-B and MAPK-responsive inflammatory genes.
Aliases: CIR1 antibody, CROC-1 antibody, CROC1 antibody, CROC1A antibody, TRAF6-regulated IKK activator 1 beta Uev1A antibody, UB2V1_HUMAN antibody, UBE2V 1 antibody, UBE2V antibody, UBE2V1 antibody, Ubiquitin conjugating enzyme E2 variant 1 antibody, Ubiquitin-conjugating enzyme E2 variant 1 antibody, UEV-1 antibody, UEV1 antibody
- UniProt
- Q13404
- Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
-